Contraceptive use in teens: a threat to bone health?
Gold
Melanie A
MA
Bachrach
Laura K
LK
D000293:Adolescent; D016497:Adolescent Health Services / Q000592:standards; D018488:Bone Demineralization, Pathologic / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D015519:Bone Density / Q000187:drug effects*; D001846:Bone Development / Q000187:drug effects; D002986:Clinical Trials as Topic; D003268:Contraception Behavior; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006266:Health Education; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011253:Pregnancy in Adolescence / Q000517:prevention & control; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate